In view of the new and mostly well-tolerated therapies, the palliative life and treatment time of oncological patients is increasingly extended. It is a major challenge to identify patients in need of palliative support in an accurate and needs-based manner, as recommended in guidelines. In the context of Germany and Switzerland, a distinction is made between general palliative care (APV) and specialized palliative care (SPV).
Autoren
- Prof. Dr. med. Birgitt van Oorschot
- Dr. med. Carmen Roch
Publikation
- InFo ONKOLOGIE & HÄMATOLOGIE
Related Topics
You May Also Like
- IBD and SARS-CoV-2
Vulnerable at the mercy of others
- Case Report
53-year-old female patient with palmoplantar keratoderma
- Diagnostics of respiratory viral infections
What is tested when and on whom?
- Incontinence
Fecal incontinence from the perspective of gastroenterology
- HER2-positive breast cancer
ENPP1 as a biomarker for poor prognosis and early detection of brain metastases
- Update 2025
Hypercholesterolemia
- GPP: from molecular principles to targeted therapy
Therapeutic rationale for targeted IL-36 receptor inhibition
- HFpEF 2025